Herpes zoster
Conditions
Interventions
Bupivacaine liposomes 0.887% (L1 group):Ultrasound guided erector spinae plane block with bupivacaine liposome concentration of 0.887%
Bupivacaine liposomes0.76% (L2 group):Ultrasound guided erector spinae plane block with bupivacaine liposome concentration of 0.76%
Bupivacaine liposomes0.665% (L3 group):Ultrasound guided erector spinae plane block with bupivacaine liposome concentration of 0.665%
Bupivacaine liposomes0.59%(L4 group):Ultrasound guided erector spinae plane block with bupivacaine liposome concentration of 0.59%
Bupivacaine liposomes0.532%(L5 group):Ultrasound guided erector spinae plane block with bupivacaine liposome concentration of 0.532%
Sponsors
Shaoxing Second Hospital
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients diagnosed with postherpetic neuralgia who came to Shaoxing Second Hospital and Zhuji Second People's Hospital for treatment. 1.Age >=18 years old; 2. Patients with confirmed diagnosis of herpes zoster in the chest, back or abdomen, and persistent pain for more than one month after skin damage has healed; 3.Visual Analog Scale (VAS) score >= 4 points.
Exclusion criteria
Exclusion criteria: 1. Patients with combined blood system, severe heart and lung dysfunction, and severe liver and kidney dysfunction; 2. Individuals with abnormal coagulation function; 3. Individuals with skin damage or local infection at the puncture site; 4. VAS score <=3 points, local rash at the treatment site has not healed; 5.Those who cannot tolerate the use of drugs in this experiment or do not agree to participate in the modified project.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Visual analogue scale,VAS; | — |
Secondary
| Measure | Time frame |
|---|---|
| Quality of sleep,QS; | — |
Countries
China
Contacts
Public ContactLu Cai
Shaoxing Second Hospital
Outcome results
None listed